Ligand is increasing its 2025 full year financial guidance. The Company now expects total core revenue of $225 million to ...

Deep in the Turkish plains lies a site older than history itself. At its heart is a structure like no other—Building AB. A new theory might finally explain what it was, and why it matters so much ...

China's steel towers in PMZ raise 'South China Sea 2.0' question: Ex-top U.S. envoy What's with the no-sail zones? More funny business in Yellow Sea as election nears China ups Yellow Sea contest by ...

CLEVELAND, Ohio - The painful moment wasn’t lost on Guardians fans last week: As Major League Baseball’s postseason unfolded, they watched a collection of former Cleveland stars shining on baseball’s ...

This video follows the construction of a £1.5 million restaurant built from modified shipping containers. The project combines industrial design with commercial functionality, highlighting the ...

The director on the Final Fantasy VII Remake trilogy has revealed during an interview with Screen Rant that the upcoming third and final entry in the project will offer a more concise structure in ...

The FDA named the first nine products to undergo a new expedited review process that takes 1 to 2 months, the agency announced on Thursday. The nine companies selected to participate in the FDA ...

The application seeks approval for Tzield (teplizumab-mzwv) to delay the progression of stage 3 type 1 diabetes in adults and pediatric patients eight years and older who have been recently diagnosed ...

SAN FRANCISCO (AP) — OpenAI said Tuesday it has reorganized its ownership structure and converted its business into a public benefit corporation, paving the way for the ChatGPT maker to more easily ...

The U.S. Food and Drug Administration (FDA) announced on Oct. 16, 2025, that it would award the first-ever Commissioner's National Priority Vouchers (CNPV) to nine recipients across various disease ...

If approved, Tzield would be the first disease-modifying therapy to delay the progression of stage 3 T1D in adults and pediatric patients eight years of age and older recently diagnosed with stage 3 ...

Sanofi’s Tzield accepted for expedited review in the US for stage 3 type 1 diabetes through FDA Commissioner's National Priority Voucher pilot program If approved, Tzield would be the first ...